THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [* * *] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.Supply and Lease Terms and Conditions • February 25th, 2008 • Novavax Inc • Biological products, (no disgnostic substances) • Delaware
This letter confirms the agreement between Novavax, Inc. (“Novavax”) and Catalent Pharma Solutions, Inc. (“Catalent”) with respect to certain supply and leasing arrangements between the parties. As we have discussed, Novavax is negotiating a potential sale of the Estrasorb™ product (the “Product”) with Graceway Pharmaceuticals, LLC (“Graceway”) and this letter agreement will be effective upon consummation of that transaction and written notice to Catalent.
